RXRX Recursion Pharmaceuticals, Inc.

Fundamentals / CIK 0001601830 / USD

Recursion Pharmaceuticals, Inc. reported $68.23M in revenue and a net loss of $475.7M for the trailing twelve months ended September 30, 2026 (up 258.5% year over year), with a 29.2% gross margin and a -725.4% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open RXRX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$141.7M$70.85M$0-$609.2MFY 2019 Revenue: $2.32MFY 2019 Net Income: -$61.88M2019FY 2020 Revenue: $3.96MFY 2020 Net Income: -$87.01M2020FY 2021 Revenue: $10.18MFY 2021 Net Income: -$186.5M2021FY 2022 Revenue: $39.84MFY 2022 Net Income: -$239.5M2022FY 2023 Revenue: $44.58MFY 2023 Net Income: -$328.1M2023FY 2024 Revenue: $58.84MFY 2024 Net Income: -$463.7M2024FY 2025 Revenue: $74.68MFY 2025 Net Income: -$644.8M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $74.68M $58.84M $44.58M $39.84M $10.18M $3.96M $2.32M
Cost of Revenue $70.95M $45.24M $42.59M $48.27M $0 $0 --
Gross Profit $3.73M $13.60M $1.99M -$8.43M $10.18M $3.96M --
Research & Development $475.3M $314.4M $241.2M $155.7M $135.3M $63.32M $45.81M
Total Operating Expenses -- -- -- -- $193.0M $88.58M $64.76M
Operating Income -$648.1M -$479.0M -$350.1M -$245.7M -$182.8M -$84.61M -$62.44M
EBITDA -$564.4M -$442.5M -$325.7M -$234.0M -$174.4M -$80.67M -$59.95M
Interest Expense $1.81M $1.57M $97K $55K $2.95M $1.36M $635K
Income Before Tax -$644.9M -$464.8M -$332.1M -$239.5M -$186.5M -- --
Income Tax Expense -$136K -$1.13M -$4.06M $0 $0 $0 $0
Net Income -$644.8M -$463.7M -$328.1M -$239.5M -$186.5M -$87.01M -$61.88M
Basic EPS -$1.44 -$1.69 -$1.58 -$1.36 -$1.49 -$3.99 -$2.87
Diluted EPS -$1.44 -$1.69 -$1.58 -$1.36 -$1.49 -$3.99 -$2.87
Basic Shares Outstanding 447.4M 274.2M 207.9M 175.5M 125.3M 21.8M 21.6M
Diluted Shares Outstanding 447.4M 274.2M 207.9M 175.5M 125.3M 21.8M 21.6M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $18.55M $7.67M $6.47M $35.54M $5.17M $19.22M $14.74M $4.55M
Cost of Revenue $10.04M $11.49M $12.49M $14.28M $14.69M $20.16M $21.83M $12.79M
Gross Profit $8.51M -$3.82M -$6.02M $21.26M -$9.51M -$938K -$7.08M -$8.25M
Research & Development $99.12M $89.61M $87.90M $95.94M $121.1M $128.6M $129.6M $98.33M
Operating Income -$123.2M -$135.0M -$128.5M -$108.3M -$172.2M -$176.2M -$191.4M -$183.8M
EBITDA -$106.6M -$116.8M -$108.8M -$88.86M -$151.2M -$152.4M -$172.0M -$170.8M
Interest Expense $266K $309K $350K -$11K $833K $480K $508K $605K
Income Before Tax -$119.0M -$131.0M -$122.1M -$108.1M -$162.2M -$171.9M -$202.6M -$178.9M
Income Tax Expense $25K -$1.0K -$4.60M $20K $3.0K $0 -$158K $7.0K
Net Income -$119.0M -$131.0M -$117.5M -$108.1M -$162.3M -$171.9M -$202.5M -$178.9M
Basic EPS -$0.22 -$0.25 -$0.22 -- -$0.36 -$0.41 -$0.50 --
Diluted EPS -$0.22 -$0.25 -$0.22 -- -$0.36 -$0.41 -$0.50 --
Basic Shares Outstanding 543.0M 532.5M 529.3M -- 447.0M 417.4M 402.8M --
Diluted Shares Outstanding 543.0M 532.5M 529.3M -- 447.0M 417.4M 402.8M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $743.3M $594.4M $391.6M $549.9M $285.1M $262.1M
Short-Term Investments -- -- -- $0 $231.4M $0
Cash & Short-Term Investments $743.3M $594.4M $391.6M $549.9M $516.6M $262.1M
Accounts Receivable, Net -- -- -- $0 $34K $156K
Other Current Assets $28.57M $38.11M $40.25M $15.87M $7.51M $2.15M
Total Current Assets $812.8M $714.3M $438.1M $569.8M $534.7M $266.4M
Property, Plant & Equipment, Net $103.9M $141.1M $86.51M $88.19M $64.72M $25.97M
Goodwill $162.2M $148.9M $52.06M $801K $801K $801K
Intangible Assets $309.9M $335.9M $36.44M $1.31M $1.39M $1.69M
Other Non-Current Assets $12.75M $8.82M $261K $0 $35K $650K
Total Non-Current Assets $661.3M $734.3M $215.6M $131.5M $75.63M $32.15M
Total Assets $1.47B $1.45B $653.7M $701.3M $610.3M $298.6M
Accounts Payable $18.12M $21.61M $3.95M $4.59M $2.82M $1.07M
Deferred Revenue (Current) $37.60M $61.77M $36.43M $56.73M $10.00M $10.00M
Total Current Liabilities $147.7M $187.5M $93.17M $100.3M $46.66M $23.10M
Long-Term Debt $9.56M $19.02M $1.10M -- $723K --
Deferred Revenue (Non-Current) $114.0M $118.8M $51.24M $70.26M $6.67M $16.67M
Other Non-Current Liabilities $2.08M $4.73M $0 -- -- --
Total Non-Current Liabilities $195.6M $226.3M $97.09M $115.2M $20.75M $33.46M
Total Liabilities $343.3M $413.8M $190.3M $215.5M $67.41M $56.56M
Total Debt (incl. Leases) $68.87M $100.1M $50.63M $50.37M $723K --
Common Stock $5.0K $4.0K $2.0K $2.0K $2.0K $0
Retained Earnings -$2.08B -$1.43B -$967.6M -$639.6M -$400.1M -$213.6M
Accumulated Other Comp. Income $36.72M -$7.64M $0 $0 -$126K $0
Total Stockholders' Equity $1.13B $1.03B $463.4M $485.8M $542.9M -$206.3M
Total Equity $1.13B $1.03B $463.4M $485.8M $542.9M -$206.3M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $549.9M $545.7M $654.5M $743.3M $659.8M $525.1M $500.5M $594.4M
Cash & Short-Term Investments $549.9M $545.7M $654.5M $743.3M $659.8M $525.1M $500.5M $594.4M
Other Current Assets $22.56M $29.32M $24.25M $28.57M $29.22M $37.34M $32.02M $38.11M
Total Current Assets $616.0M $603.5M $709.6M $812.8M $714.1M $587.2M $584.1M $714.3M
Property, Plant & Equipment, Net $85.84M $89.62M $95.81M $103.9M $111.7M $120.0M $126.8M $141.1M
Goodwill $160.7M $160.3M $160.2M $162.2M $162.0M $164.3M $158.1M $148.9M
Intangible Assets $273.7M $282.9M $294.1M $309.9M $322.3M $341.3M $335.8M $335.9M
Other Non-Current Assets $12.63M $12.19M $12.25M $12.75M $14.66M $9.42M $14.78M $8.82M
Total Non-Current Assets $605.7M $609.2M $630.0M $661.3M $685.4M $715.2M $721.1M $734.3M
Total Assets $1.22B $1.21B $1.34B $1.47B $1.40B $1.30B $1.31B $1.45B
Accounts Payable $16.38M $12.67M $20.35M $18.12M $13.94M $19.31M $25.09M $21.61M
Deferred Revenue (Current) $15.81M $27.59M $32.79M $37.60M $47.36M $39.69M $39.65M $61.77M
Total Current Liabilities $122.9M $119.9M $129.7M $147.7M $155.1M $164.0M $142.0M $187.5M
Long-Term Debt $93K $4.75M $7.18M $9.56M $11.90M $14.20M $16.45M $19.02M
Deferred Revenue (Non-Current) $120.0M $112.8M $114.7M $114.0M $111.2M $126.2M $129.6M $118.8M
Other Non-Current Liabilities $3.96M $2.70M $2.02M $2.08M $1.03M $1.56M $4.79M $4.73M
Total Non-Current Liabilities $193.0M $177.8M $185.1M $195.6M $197.5M $219.2M $229.3M $226.3M
Total Liabilities $315.9M $297.7M $314.8M $343.3M $352.6M $383.2M $371.3M $413.8M
Total Debt (incl. Leases) $62.89M $57.20M $63.11M $68.87M $73.45M $79.32M $84.32M $100.1M
Common Stock $6.0K $5.0K $5.0K $5.0K $5.0K $4.0K $4.0K $4.0K
Retained Earnings -$2.44B -$2.32B -$2.19B -$2.08B -$1.97B -$1.81B -$1.63B -$1.43B
Accumulated Other Comp. Income $29.63M $27.99M $26.66M $36.72M $34.09M $43.62M $14.14M -$7.64M
Total Stockholders' Equity $905.8M $915.0M $1.02B $1.13B $1.05B $919.1M $933.9M $1.03B
Total Equity $905.8M $915.0M $1.02B $1.13B $1.05B $919.1M $933.9M $1.03B

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$644.8M -$463.7M -$328.1M -$239.5M -$186.5M -$87.01M -$61.88M
Depreciation & Amortization $83.70M $36.49M $24.40M $11.76M $8.40M $3.94M $2.49M
Stock-Based Compensation $111.2M $81.69M $53.50M $27.91M $14.84M $4.29M $1.39M
Change in Receivables -- -- -- -- $114K -$5.0K -$27K
Change in Payables -$2.62M $6.43M -$987K $1.77M $1.75M -$185K -$340K
Operating Cash Flow -$371.8M -$359.2M -$287.8M -$83.52M -$158.6M -$45.40M -$57.04M
Capital Expenditure -$6.47M -$13.70M -$11.96M -$37.06M -$39.80M -$5.83M -$3.91M
Free Cash Flow -$378.3M -$372.9M -$299.7M -$120.6M -$198.4M -$51.23M -$60.95M
Acquisitions, Net $0 $277.1M $1.84M $0 $0 -$2.60M $0
Purchases of Investments -$3.81M $0 $0 $0 -$301.1M $0 $0
Investing Cash Flow -$16.87M $260.1M -$10.23M $193.2M -$271.7M -$8.74M -$3.91M
Common Stock Issued $528.9M $300.4M $128.1M $143.7M $462.9M $0 --
Financing Cash Flow $521.5M $304.1M $140.1M $154.3M $458.5M $246.1M $120.4M
Net Change in Cash $150.9M $201.6M -$157.7M $263.8M $28.18M $192.0M $59.46M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$119.0M -$131.0M -$117.5M -$108.1M -$162.3M -$171.9M -$202.5M -$178.9M
Depreciation & Amortization $16.54M $18.17M $19.67M $19.48M $21.04M $23.85M $19.33M $12.95M
Stock-Based Compensation $23.03M $19.50M $22.21M $23.76M $25.24M $26.16M $36.06M $30.78M
Change in Payables $3.97M -$7.67M $2.07M $4.42M -$5.89M -$4.84M $3.69M $8.12M
Operating Cash Flow -$77.41M -$105.9M -$81.10M -$46.07M -$117.4M -$76.42M -$132.0M -$115.4M
Capital Expenditure -$407K -$44K -$258K -$1.24M -$243K -$3.15M -$1.83M -$1.30M
Free Cash Flow -$77.81M -$106.0M -$81.36M -$47.32M -$117.6M -$79.57M -$133.8M -$116.7M
Purchases of Investments $0 $0 $0 $0 -$2.31M -$500K -$1.00M $0
Investing Cash Flow -$407K -$1.96M -$338K -$1.24M -$2.55M -$5.81M -$7.27M $275.5M
Common Stock Issued $85.52M $0 $0 $133.4M $254.5M $100.0M $41.02M $11.03M
Financing Cash Flow $83.14M -$1.27M -$3.47M $132.0M $251.3M $97.66M $40.53M $10.64M
Net Change in Cash $4.71M -$108.4M -$88.74M $86.78M $133.3M $24.69M -$93.87M $167.2M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 5.0% 23.1% 4.5% -21.2% 100.0% 100.0% --
Operating Margin -867.9% -814.1% -785.3% -616.7% -1795.8% -2135.7% -2692.6%
Net Profit Margin -863.4% -788.0% -736.0% -601.0% -1832.2% -2196.0% -2668.3%
Return on Equity (ROE) -57.0% -44.8% -70.8% -49.3% -34.3% -- --
Return on Assets (ROA) -43.7% -32.0% -50.2% -34.1% -30.6% -29.1% --
Current Ratio 5.50x 3.81x 4.70x 5.68x 11.46x 11.53x --
Quick Ratio 5.03x 3.17x 4.20x 5.48x 11.07x 11.35x --
Debt to Equity 0.06x 0.10x 0.11x 0.10x 0.00x -- --
Revenue Growth (YoY) +26.9% +32.0% +11.9% +291.5% +156.9% +70.8% --
Gross Profit Growth (YoY) -72.6% +584.2% -- -182.8% +156.9% -- --
5Y Revenue / Share Growth -8.2% +99.6% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 29.2% 3.5% 7.2% 5.0% -59.0% -3.5% 6.5% 23.1%
Operating Margin -725.4% -991.7% -881.3% -867.9% -1656.2% -1005.8% -960.1% -814.1%
Net Profit Margin -697.1% -945.9% -842.9% -863.4% -1637.8% -1004.9% -961.3% -788.0%
Return on Equity (ROE) -52.5% -56.7% -54.6% -57.0% -68.3% -70.6% -61.5% -44.8%
Return on Assets (ROA) -38.9% -42.8% -41.8% -43.7% -51.1% -49.8% -44.0% -32.0%
Current Ratio 5.01x 5.03x 5.47x 5.50x 4.60x 3.58x 4.11x 3.81x
Quick Ratio 4.47x 4.55x 5.05x 5.03x 4.25x 3.20x 3.52x 3.17x
Debt to Equity 0.07x 0.06x 0.06x 0.06x 0.07x 0.09x 0.09x 0.10x
Revenue Growth (YoY) +258.5% -60.1% -56.1% +681.7% -80.2% +33.3% +6.9% -58.3%
Gross Profit Growth (YoY) -- -- -- -- -167.9% -118.0% -369.6% -916.6%
Source: SEC EDGAR CompanyFacts (CIK 0001601830) · from December 31, 2019 Data through September 30, 2026 · synced Nov 20, 2026, 05:22 UTC · Open in terminal